~~<i id='C96C230BD4'><strike id='C96C230BD4'><tt id='C96C230BD4'><pre id='C96C230BD4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

knowledge

author：Wikipedia 2025-10-01 21:37:26 - browse：6978

Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT — Adobe

For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

But don’t take their numbers as gospel, experts warned.

“It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Health insurers say they are turning to AI to cut costs, improve care

focus

entertainment

focus

hotspot

explore

Wikipedia

Adobe’Tistheseason—openenrollmentseason,thatis.SincebeforetheNov.1 starttotheannualopenenrollmentper

WSS

Brain injuries and the importance of a second opinion

Lab trade group sues FDA to halt regulation of lab

Medicare proceeds with plan to claw back hospital funds

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Explaining an after

Travis Kelce and the trap of celebrity vaccine endorsements

explore

knowledge

focus

Sports medicine is finally prioritizing gender equality

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Apple is now the first public company to be valued at $3 trillion

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Psychedelics group wrestles with new pharma identity

Inari Medical to buy amputation prevention company LimFlow

Medicare proposal to cover medical devices draws a mixed reaction

Kidney transplant patients stopped immunosuppressants in trial

How one medical school became remarkably diverse

How to convince healthy people to buy insurance

entertainment

Do more moles mean more problems? Not so, says new study

Coloradans with cystic fibrosis could lose access to Trikafta

Dark money group runs ads on China biotech bill

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Explaining an after

focus

hotspot

explore

Wikipedia